Gyre Therapeutics Inc. (GYRE)

Market Closed

1 Sep, 20:00

NASDAQ (CM)

6. 47

-0.1

-1.5221%

After Hours

6. 61

+0.14 +2.1638%

732.48M Market Cap

- P/E Ratio

0.96% Div Yield

54,546 Volume

- Eps

$ 6.57

Previous Close

Investors:

Add Transaction

Day Range

6.33 6.57

Year Range

5.44 9.42

Want to track GYRE and more in your Portfolio? 🎯

Get Started For Free

Gyre Therapeutics, Inc. (GYRE) Reports Q2 Loss, Beats Revenue Estimates

Gyre Therapeutics, Inc. (GYRE) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to earnings of $0.02 per share a year ago.

Zacks | 3 weeks ago

Gyre Therapeutics, Inc. (GYRE) Reports Q1 Loss, Lags Revenue Estimates

Gyre Therapeutics, Inc. (GYRE) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to break-even earnings per share a year ago.

Zacks | 3 months ago

Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates

Gyre Therapeutics, Inc. (GYRE) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.01 per share a year ago.

Zacks | 5 months ago

Gyre Therapeutics, Inc. (GYRE) Q3 Earnings Surpass Estimates

Gyre Therapeutics, Inc. (GYRE) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.02 per share a year ago.

Zacks | 9 months ago

Blog Affiliate Program About Terms Privacy Help Contact Us